Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers von Harrington, K J, Billingham, L J, Brunner, T B, Burnet, N G, Chan, C S, Hoskin, P, Mackay, R I, Maughan, T S, Macdougall, J, McKenna, W G, Nutting, C M, Oliver, A, Plummer, R, Stratford, I J, Illidge, T

Volltext

HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer) von Plowright, L, Harrington, K J, Pandha, H S, Morgan, R

Volltext

OX40 and 4-1BB delineate distinct immune profiles in sarcoma von Melake, MJ, Smith, HG, Mansfield, D, Davies, E, Dillon, MT, Wilkins, AC, Patin, EC, Pedersen, M, Buus, R, Melcher, AA, Thway, K, Miah, AB, Zaidi, SH, Hayes, AJ, Fenton, TR, Harrington, KJ, McLaughlin, M

Volltext

Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity von Ilett, E J, Prestwich, R J, Kottke, T, Errington, F, Thompson, J M, Harrington, K J, Pandha, H S, Coffey, M, Selby, P J, Vile, R G, Melcher, A A

Volltext

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial von White, C L, Twigger, K R, Vidal, L, De Bono, J S, Coffey, M, Heinemann, L, Morgan, R, Merrick, A, Errington, F, Vile, R G, Melcher, A A, Pandha, H S, Harrington, K J

Volltext

Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma von Nutting, C.M., van Herpen, C.M.L., Miah, A.B., Bhide, S.A., Machiels, J.-P., Buter, J., Kelly, C., de Raucourt, D., Harrington, K.J.

Volltext

Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck von del Campo, J M, Hitt, R, Sebastian, P, Carracedo, C, Lokanatha, D, Bourhis, J, Temam, S, Cupissol, D, De Raucourt, D, Maroudias, N, Nutting, C M, Compton, N, Midwinter, D, Downie, L, Biswas-Baldwin, N, El-Hariry, I, Harrington, K J

Volltext

Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers von BHIDE, S. A, NEWBOLD, K. L, HARRINGTON, K. J, NUTTING, C. M

Volltext

Review article: gene therapy, recent developments and future prospects in gastrointestinal oncology von Touchefeu, Y., Harrington, K. J., Galmiche, J. P., Vassaux, G.

Volltext

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma von Errington, F, White, C L, Twigger, K R, Rose, A, Scott, K, Steele, L, Ilett, L J, Prestwich, R, Pandha, H S, Coffey, M, Selby, P, Vile, R, Harrington, K J, Melcher, A A

Volltext

Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy von Ismail, M, Bokaee, S, Davies, J, Harrington, K J, Pandha, H

Volltext

Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer von Kirby, A M, A'Hern, R P, D'Ambrosio, C, Tanay, M, Syrigos, K N, Rogers, S J, Box, C, Eccles, S A, Nutting, C M, Harrington, K J

Volltext

Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk von Dean, J.A, Welsh, L.C, Wong, K.H, Aleksic, A, Dunne, E, Islam, M.R, Patel, A, Patel, P, Petkar, I, Phillips, I, Sham, J, Schick, U, Newbold, K.L, Bhide, S.A, Harrington, K.J, Nutting, C.M, Gulliford, S.L

Volltext

The effect of parotid gland‐sparing intensity‐modulated radiotherapy on salivary composition, flow rate and xerostomia measures von Richards, TM, Hurley, T, Grove, L, Harrington, KJ, Carpenter, GH, Proctor, GB, Nutting, CM

Volltext

Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin–paclitaxel doublet chemotherapy von Roulstone, V, Twigger, K, Zaidi, S, Pencavel, T, Kyula, J N, White, C, McLaughlin, M, Seth, R, Karapanagiotou, E M, Mansfield, D, Coffey, M, Nuovo, G, Vile, R G, Pandha, H S, Melcher, A A, Harrington, K J

Volltext

Oncolytic Vaccinia virus and radiotherapy in head and neck cancer von Mansfield, D, Pencavel, T, Kyula, J.N, Zaidi, S, Roulstone, V, Thway, K, Karapanagiotou, L, Khan, A.A, McLaughlin, M, Touchefeu, Y, Seth, R, Melcher, A.A, Vile, R.G, Pandha, H.S, Harrington, K.J

Volltext

Equivalence of cisplatin and carboplatin-based chemoradiation for locally advanced squamous cell carcinoma of the head and neck: A matched-pair analysis von Wilkins, A.C, Rosenfelder, N, Schick, U, Gupta, S, Thway, K, Nutting, C.M, Harrington, K.J, Newbold, K, Bhide, S.A

Volltext

Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer von Bhide, S A, Ahmed, M, Barbachano, Y, Newbold, K, Harrington, K J, Nutting, C M

Volltext

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer von Simpson, G R, Horvath, A, Annels, N E, Pencavel, T, Metcalf, S, Seth, R, Peschard, P, Price, T, Coffin, R S, Mostafid, H, Melcher, A A, Harrington, K J, Pandha, H S

Volltext

Phase I-II study of pegylated liposomal cisplatin (SPI-077 TM) in patients with inoperable head and neck cancer von Harrington, K. J., Lewanski, C. R., Northcote, A. D., Whittaker, J., Wellbank, H., Vile, R. G., Peters, A. M., Stewart, J. S. W.

Volltext